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Apoptosis has an essential role in controlling T cell homeostasis, especially during the contraction phase of an immune
response. However, its contribution to the balance between effector and regulatory populations remains unclear. We found that
Rag1
 /  hosts repopulated with Bim
 /  conventional CD4
þ T cells (Tconv) resulted in a larger induced regulatory T cell (iTreg)
population than mice given wild-type (WT)Tconv. This appears to be due to an increased survival advantage of iTregs compared
with activated Tconv in the absence of Bim. Downregulation of Bcl-2 expression and upregulation of Bim expression were more
dramaticinWTiTregsthanactivatedTconvintheabsenceofIL-2invitro.TheiTregsgeneratedfollowingTconvreconstitutionof
Rag1
 /  hosts exhibited lower Bcl-2 expression and higher Bim/Bcl-2 ratio than Tconv, which indicates that iTregs were in an
apoptosis-prone state in vivo. A signiﬁcant proportion of the peripheral iTreg pool exhibits low Bcl-2 expression indicating
increased sensitivity to apoptosis, which may be a general characteristic of certain Treg subpopulations. In summary, our data
suggest that iTregs and Tconv differ in their sensitivity to apoptotic stimuli due to their altered ratio of Bim/Bcl-2 expression.
Modulating the apoptosis pathway may provide novel therapeutic approaches to alter the balance between effector T cells and
Tregs.
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Regulatory T cells (Tregs) are an important subpopulation of
CD4
þ T cells that have a critical role in maintaining immune
homeostasis and tolerance. Tregs can be divided into natural
Tregs (nTreg), that develop in the thymus, and induced Tregs
(iTreg), that develop from conventional CD4
þ T cells (Tconv)
in the periphery during an immune response. iTregs can be
induced in response to either increased expression of self-
antigen or as a consequence of infection. Therefore, their
homeostasis must be tightly controlled. Insufﬁcient differen-
tiation of iTregs may result in immune pathogenesis, whereas
prolonged survival of these cells may compromise the
establishment of immune memory. Although signiﬁcant in-
sight has been obtained concerning Treg development and
differentiation,
1 little is known about the molecular mechan-
ism(s) controlling nTreg and iTreg survival.
2–5
TheBH3-only familymember Bim (encoded by Bcl2l11)isa
pro-apoptotic molecule that controls the coordinated contrac-
tion of the immune T cell response.
6–9 It directly interacts with
and deactivates the anti-apoptotic regulators Bcl-2 and Bcl-xl.
Thus, the ﬁne balance between Bim and Bcl-2/Bcl-xl expres-
sion levels represents an important checkpoint for cell
survival.
10,11 Despite enhanced peripheral T cell expansion,
Bim
 /  mice do not develop aggressive T cell-mediated
autoimmune disease.
12 This may be due in part to
an increased Treg population in moderately aged Bim
 / 
animals compared with their wild-type (WT) littermates.
13,14
Interestingly, Bim expression naturally declines in peripheral
WT CD4
þ T cells during aging,
15 which is co-incident with
increasing numbers of Tregs. This raises the possibility that
Bim has an important role in Treg homeostasis.
As iTregs and nTregs cannot be distinguished in Bim
 / 
animals, the impact that Bim depletion has on either Treg cell
subtype remains unclear. It appears that depletion of Bim
may have a limited impact on nTreg development, as the
emigration rate of nTregs from the thymus is similar in WT and
Bim
 /  mice.
13 The observation that Bim
 /  nTregs are more
proliferative is, however, contradictory to the observation that
Bim
 /  T cells are hypo-responsive upon TCR activation.
16 In
thisstudy,weaskifthebalancebetweenBimandBcl-2actsas
a critical survival parameter that controls iTreg homeostasis.
Results
Preferential induction of iTregs in vivo in the absence of
Bim. To directly investigate the inﬂuence of Bim depletion on
iTreg homeostasis in vivo, we induced inﬂammatory bowel
disease (IBD) in mice by adoptively transferring CD4
þ
CD25
 CD45RB
hi Tconv into Rag1
 /  hosts. In this model,
transferred Tconv repopulate the host lymphoid tissue,
leading to intestinal inﬂammation in a certain percentage of
Tconv recipients. As only Tconv are transferred (Supplemen-
tary Figure S1a), essentially all Foxp3
þ T cells recovered
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Cell Death and Diseasefrom the recipients are de novo-generated iTregs. Although
Bim is important for T-cell apoptosis, we only observed a
slight difference between Bim
 /  and WT Tconv recipients in
both percentage and absolute number of CD4
þ T cells
recovered from the spleens and mesenteric lymph nodes
(MLN) (Figures 1a and b). Surprisingly, there was a
signiﬁcant increase in the percentage (B2–3-fold) and
number (B3–4-fold) of Foxp3
þCD4
þ iTregs recovered
from Bim
 /  Tconv recipients compared with WT Tconv
recipients in the spleen, MLN and a combined population of
intraepithelial lymphocytes and lamina propria lymphocytes
(IEL/LPL) isolated from the intestines (Figures 1c and d).
This increase of iTregs did not appear to be due to differing
levels of Foxp3 protein expression, as iTregs recovered from
both Bim
 /  and WT Tconv recipients exhibited comparable
levels of Foxp3 expression (spleen¼1022/958 (WT/Bim
 / 
MFI); MLN¼1649/1443; intestine¼1272/1258; Figure 1e).
Nor was the difference due to an increased ability of Bim
 / 
Tconv to expand, compared with WT Tconv following transfer
into a lymphopenic host, as the percentage of BrdU uptake
by CD4
þFoxp3
  cells was similar in the spleen and
surprisingly higher in WT cells in the MLN (Figure 1f and
Supplementary Figure S1b). This difference, however, was
minimal in terms of the number of CD4
þFoxp3
 BrdU
þ cells
(Supplementary Figure S1c). Interestingly, there was an
increased percentage and number of Bim
 /  CD4
þFoxp3
þ
BrdU
þ cells in the spleen (Figure 1f and Supplementary
Figure S1c). This may partially explain the larger fold
difference between the number of Bim
 /  iTregs and WT
iTregs in the spleen (B3-fold difference) compared with MLN
(B2-fold difference).
Consistent with these data, mice that received Bim
 / 
Tconv had an B50% reduction in the incidence of IBD
(as measured by weight loss greater than 5% initial body
weight) than WT Tconv recipients (P¼7.52 10
 5; relative
risk¼0.491; 95% CI (0.346–0.700); Figure 1g). Taken
together, these data suggest that the loss of Bim has a
preferential effect on the generation and/or survival of iTregs,
compared with the proportion of transferred Tconv that do not
converttoaFoxp3
þ population,resultinginaprotectiveeffect
against IBD.
Loss of Bim confers a preferential survival advantage for
iTregs. The increase in iTregs observed in the Bim
 / 
Tconv recipients could be a consequence of increased
efﬁciency of the Bim
 /  iTreg conversion, a selective survival
advantage of Bim
 /  iTregs due to increased IL-2 secretion
by Bim
 /  Tconv, or an accumulated effect due to an intrinsic
survival advantage in iTregs versus Tconv in the absence of
Bim. To address the ﬁrst possibility, we performed an in vitro
iTreg conversion assay. Multiple factors are able to modulate
the efﬁciency of iTreg conversion. TCR signaling is known to
have a pivotal effect. Enhanced TCR activation with higher
proliferative capacity leads to more efﬁcient iTreg
differentiation in vitro (Supplementary Figures S2a and b)
and in vivo.
17 As recent studies have suggested that Bim
 / 
Tconv are hyporeactive to TCR stimulation,
16 one might
predict that Bim
 /  Tconv may not show a differentiation
advantage over WT Tconv. Consistent with this notion, Bim
 / 
Tconv exhibited less efﬁcient iTreg conversion in vitro than
WT Tconv (Supplementary Figure S2c), which was likely due
to less efﬁcient TCR activation. It is possible that Bim
 / 
Tconv secrete more IL-2, leading to enhanced conversion and
survival of iTregs. However, this did not seem to be likely as
WT and Bim
 /  Tconv activated in vitro secrete similar
amounts of IL-2 (Supplementary Figure S2d). Furthermore,
the percentage of CD4
þCD25
 IL-2
þ cells isolated from
Rag1
 /  mice that received either WT or Bim
 /  Tconv was
equivalent (Supplementary Figure S2e).
The third possibility is that Bim depletion has a differential
effect on the survival of iTregs versus Tconv. Constitutive
expression of the IL-2 receptor (CD25) is a hallmark for nTregs
and it is well known that they are highly dependent on IL-2 for
their homeostasis and survival.
18,19 Given the fact that Bim is a
principal component in growth factor deprivation-mediated
apoptosis, we compared the survival capacity of WT and
Bim
 /  iTregs, and activated Tconv in the absence of IL-2.
The iTregs were generated by activating puriﬁed Tconv from
Foxp3
GFPreportermice in thepresenceofTGF-band IL-2 for 3
days. Foxp3
þ iTregs (GFP
þ) and activated Foxp3
  Tconv
(GFP
 )weresorted,cultured in theabsence ofexogenousIL-2
and their relative survival compared. We found that Foxp3
þ
iTregs had a two-fold increase intheir sensitivitytoapoptosisin
cultures without the addition of exogenous IL-2, compared with
Foxp3
 -activated Tconv (Figures 2a and b). Foxp3
þ iTregs
were more vulnerable to apoptosis than Foxp3
 -activated
Tconv over a wide range of limited exogenous IL-2 supple-
mentation (from 10U/ml to 100U/ml; Figure 2c). However,
these differences in survival capacity between iTregs and
activated Tconv were abrogated in both cell populations in the
absence of Bim (Figures 2a and b). These data suggest that
iTregs are more sensitive to IL-2 deprivation-mediated apop-
tosis than activated Tconv. Loss of Bim expression confers a
greater survival advantage for Foxp3
þ iTregs, nullifying their
increased sensitivity to growth factor withdrawal.
Intrinsic vulnerability to apoptosis due to altered Bim,
Bcl-2 and Bcl-xl balance in iTregs. We next investigated
the mechanism responsible for the survival disparity between
iTreg and activated Tconv in the presence of limited IL-2.
Activated T cells only express IL-2 transiently following TCR
engagement. Blocking IL-2 signaling by using an anti-CD25
Figure1 EnhancedinvivoiTreginductionanddecreasedincidenceofIBDintheabsenceofBim.TconvweresortedfromthespleenandlymphnodesofC57BL/6(WT)or
Bim
 /  mice and injected i.v. into the tail veins of Rag1
 /  recipients (0.4 10
6 cells per mouse). Four weeks post-transfer, spleen, MLN and IEL/LPL (intestine) were
analyzed by ﬂow cytometry. Percentage and number of CD4
þ (a and b) and CD4
þFoxp3
þ (c and d) cells. Data are the mean±S.E. of two to three individual experiments
with ﬁve to seven mice per group (a d), and statistical analysis performed using standard unpaired t-test (*Po0.05, **Po0.01). (e) Representative dot plots of
CD4
þFoxp3
þ iTregs. (f) Percentage of BrdU
þ Tconv (CD4
þFoxp3
 , left) and iTregs (CD4
þFoxp3
þ, right). Data are the mean±S.E. of two independent experiments
with four mice per group, and statistical analysis performed using standard unpaired t-test (*Po0.05, **Po0.01). (g) Incidence of IBD in Tconv recipients and statistical
summary (2 2 w
2-analysis)
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Cell Death and Diseaseantibody had little effect on activated Tconv survival in the
absence of exogenous IL-2 addition. Thus, the survival
advantage of activated Tconv over iTregs under limiting IL-2
conditions was likely due to cell intrinsic mechanisms rather
than an autocrine IL-2 pathway.
As deletion of the pro-apoptotic molecule Bim was able to
mitigatethesurvivaldifferencesbetweeniTregsandactivated
Tconv,wecomparedtheexpressionlevelsofseveralpro-and
anti-apoptotic Bcl-2 family members in iTregs and activated
Tconv before (pre) and after (post) a 2-day culture in the
absence of exogenous IL-2 (Figure 3a). The expression of the
pro-apoptotic members of the Bcl-2 family, Bim and Bax, was
increased to a similar extent in iTregs and activated Tconv
(change between expression pre- and post-IL-2 removal). No
change in Bid expression level was observed. Expression of
the anti-apoptotic molecules Bcl-2 and Bcl-xl was slightly
higher in iTregs compared with activated Tconv before IL-2
withdrawal (Figure 3a; noted as ‘pre’). However, culturing
cells in the absence of exogenous IL-2 for just 48h resulted in
a much more dramatic decrease of Bcl-2 expression in
iTregs compared with activated Tconv, which was accom-
panied with a larger increase of Bim expression (Figure 3a;
noted as ‘post’). Similar but less pronounced changes
were observed with Bcl-xl and Bax. Mcl-1 and Noxa
have recently been shown to be important in regulating
T-cell apoptosis during clonal expansion.
20 Despite substan-
tial upregulation of Noxa following T-cell activation, there
was no difference in the relative expression of Mcl-1 and
Noxa mRNA between Tconv and iTregs (Supplementary
Figure S3).
As cell survival is dependent on the balance between
pro- and anti-apoptotic molecules rather than their absolute
expression levels, analysis of the relative ratios of interactive
partnersmaybeaninformativeparametertoelucidatecellular
sensitivity to apoptosis. Minimal differences in the Bim/Bcl-2,
Bim/Bcl-xl, Bax/Bcl-2 and Bax/Bcl-xl expression ratios were
observed between freshly sorted iTregs and activated Tconv
(Figure 3b; pre), suggesting that their initial sensitivity to
apoptosis may be similar. However, continued culture in the
absence of IL-2 resulted in a signiﬁcant increase in the Bim/
Bcl-2 expression ratio in iTregs (B7-fold – pre versus post)
versus activated Tconv (B3-fold). There was also an B3-fold
increase in the Bim/Bcl-xl ratio in iTregs, which was not
observed with activated Tconv (Figure 3b). Similar changes
were observed with the Bax/Bcl-2 or Bax/Bcl-xl ratios. As
anticipated, IL-2 supplementation prevented the increase of
Bim/Bcl-2 ratio, which correlated with their capacity to
promote iTreg survival to a level comparable to activated
Tconv(SupplementaryFigureS4).ConsistentwiththismRNA
analysis, we observed a much larger proportion of iTregs that
lost intracellular Bcl-2 protein expression following IL-2
withdrawal, compared with activated Tconv (Figure 3c).
Collectively, these data suggest that iTregs are intrinsically
less capable of maintaining an appropriate balance between
thepro-(Bim/Bax)andanti-(Bcl-2/Bcl-xl)apoptoticproteinsto
ensure survival.
Reduced Bcl-2 expression in iTregs in vivo. To extend
our ﬁndings in vivo, we transferred the Foxp3
GFP Tconv or
CD4
þCD25
 CD45RB
hi Tconv from WT mice into Rag1
 / 
recipients and analyzed the expression levels of the Bcl-2
family molecules in iTregs and Tconv recovered 4 weeks
post-transfer. Although expression levels of Bim, Bcl-xl and
Bax were fairly comparable between iTreg and Tconv, iTregs
consistently expressed four to ﬁve times less Bcl-2 than
Tconv recovered from the spleen (Figure 4a). Consequently,
the Bim/Bcl-2 and Bax/Bcl-2 mRNA ratios were substantially
Figure 2 Preferential role of the Bim/Bcl-2 axis in controlling iTreg survival.
(aandb)TconvwereisolatedfromWTorBim
 / Foxp3
GFPmiceandactivatedwith
anti-CD3/CD28-coated beads in the presence of TGF-b (5ng/ml) and IL-2 (100U/
ml) for 3 days to induce iTreg differentiation. The iTregs (GFP
þ) and activated
Tconv (GFP
 ) were then sorted by FACS and cultured for additional 3 days in the
absence of IL-2. Percentage of live iTregs and Tconv was determined by ﬂow
cytometry with propidium iodide (PI) and anti-Annexin V. Data are the mean±S.E.
of four independent experiments with statistical analysis performed using standard
paired t-test (*Po0.05). (c) iTregs (GFP
þ) and activated Tconv (GFP
 ) were
culturedinthepresenceof variousIL-2concentrationsfor 3daysandpercentageof
live cells determined by PI and anti-Annexin V. Data is representative of two
independent experiments
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Cell Death and DiseaseFigure 3 Intrinsic vulnerability of Bim, Bcl-2 and Bcl-xl balance in iTregs. (a and b) iTregs and activated Tconv were prepared as in Figure 2. mRNA was isolated from
eitherfreshlysortediTregs(Foxp3
þ)andactivatedTconv(Foxp3
 ),before(pre)orafteran additional48hofcultureintheabsenceofIL-2(post).Expressionlevelsofgenes
indicated was assessed by qPCR. Data shown are the mean±S.E. from ﬁve independent experiments with statistical analysis performed using standard paired t-test
(*Po0.05,**Po0.01,***Po0.005).(c)IntracellularBcl-2offreshlysortediTregs(Foxp3
þ)andactivatedTconv(Foxp3
 )before(pre)orafteranadditional48hofculturein
the absence of IL-2 (post). Data represent two independent experiments
Figure 4 ReducedBcl-2expressioniniTregsinvivo.Foxp3
GFPTconvorCD4
þCD25
 CD45RB
hicellsfromWTorBim
 / mice(0.5 10
6)weretransferredintoRag1
 / 
hosts. (a–c) Four weeks post transfer, iTregs (GFP
þ cells) and Tconv (GFP
  cells) were isolated by FACS, mRNA prepared, and expression of the genes indicated was
determined by qPCR. Data shown are representative of three independent experiments with statistical analysis performed using the Mann–Whitney test( * Po0.01). (d and e)
Four weeks post-transfer, iTregs and Tconv from the spleen, non-draining lymph nodes (ndLN), MLN and IEL/LPL were analyzed for intracellular Bcl-2 and Foxp3 by ﬂow
cytometry.Dataaremean±S.E.ofthreeindividual experimentswith 11–12individualmice,with statisticalanalysisperformed usingstandardunpairedt-testcomparingTconv/
iTreg and iTreg in the spleen/MLN (*Po0.05, ***Po0.005)
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Cell Death and Diseasehigher in iTregs than in Tconv (Figures 4b and c). No
difference in Bax/Bcl-xl ratio was observed (Figure 4c).
Interestingly, Bcl-2 mRNA expression in iTregs and Tconv
recovered from the MLN was similar, which mirrored our
observation that there was a somewhat less profound
increase in the number of iTregs in MLN versus the spleen
in the absence of Bim (Figures 1c and d). Given that the MLN
serves as the primary site of immune response in the IBD
model, it is possible that the levels of growth factors such as
IL-2 are more abundant here compared with more distal
lymphoid tissues such as the spleen.
Intracellular Bcl-2 protein staining conﬁrmed that iTregs
consistently express less Bcl-2 (B3-fold) compared with
Foxp3
  Tconv isolated from the spleen, non-draining lymph
nodes, MLN and IEL/LPL of repopulated Rag1
 /  hosts
(Figures 4d and e). This was also observed with cells isolated
from Rag1
 /  hosts repopulated with Bim
 /  Tconv
(Figure 4e). Bcl-2 expression in iTregs was also consistently
higher in the MLN. Collectively, iTregs seem to have a
deﬁciency in Bcl-2 expression, which may render them more
susceptible to apoptosis in vivo.
Foxp3
þBcl2
lo Treg populations in vivo. The nTregs
are reported to express higher levels Bcl-2 than Tconv.
21 If
low expression of Bcl-2 is a characteristic feature of iTregs,
in comparison with nTregs, we asked whether it could
potentially mark iTregs in WT C57BL/6 mice in vivo.
Consistent with our hypothesis, there were clearly two
populations of Tregs, distinguishable as Bcl-2
lo and Bcl-2
hi
in the spleen and peripheral lymph nodes, respectively
(Figure 5a). Although Bcl-2 expression levels in Tregs did not
correlate with Helios expression, a suggested marker of
iTregs,
22,23 about 50% of the Bcl-2
lo Tregs were CD69
lo and
CD44
hi, suggesting that this Treg population was antigen-
experienced but not recently activated (Figures 5a and b).
Therefore, although we cannot exclude the possibility that a
proportion of the Bcl-2
lo Tregs were derived from nTregs
after recent activation, it is possible that Foxp3
þ
Bcl-2
loCD69
hiCD44
hi cells represent newly differentiated
iTregs, whereas Foxp3
þBcl-2
loCD69
loCD44
hi cells represent
a memory iTreg population.
24 However, further analysis would
be required to determine if nTregs and iTregs can be
distinguished by the level of Bcl-2 expression.
Discussion
Previous studies have reported increased numbers of Tregs
in Bim
 /  mice, as well as in aged mice.
13,14 However, the
mechanisms that control the homeostasis of Treg populations
remain to be fully deﬁned. It has been suggested that
increased proliferation of Bim
lo Tregs (marked by increased
BrdU incorporation in the Foxp3
þBim
lo population) was the
basis for preferential Treg expansion.
13 However, this model
is somewhat controversial as studies have suggested that
responses following TCR stimulation are defective in Bim
 / 
and Bim
lo T cells.
15,16 Our data suggest that decreased Bim
expression confers a preferential survival advantage on
iTregs. Therefore, depletion or downregulation of Bim limits
the rapid peripheral Treg cell turnover,
25 which consequently
results in increased Treg numbers. As optimal TCR signaling
is required for iTreg differentiation, and the T-cell population
with the highest proliferative capacity tends to differentiate
into iTregs more efﬁciently, higher BrdU incorporation in
the Foxp3
þBim
lo T-cell population may represent enhanced
iTreg survival due to lower Bim expression in vivo rather than
nTregexpansion.Inlinewithourmodel,overexpressionofthe
anti-apoptotic molecule Bcl-2 in T cells also results in an
increased proportion of iTregs in vivo and reduces the
incidence of autoimmune disease.
26
Theimportanceof IL-2inthe developmentandhomeostatic
maintenance of nTregs, iTreg and Tconv is well documen-
ted.
18,19,27 IL-2- or IL-2R-deﬁcient mice have a two-fold
reduction in the number of Tregs and suffer from a severe
lymphoproliferative disease.
2,28 However, crossing IL-2- or IL-2R-
deﬁcient mice with Bim
 /  mice eliminated this numerical
deﬁciency, supporting our data that demonstrates the level of
vBim expression is important for iTreg survival.
28 Never-
theless, restoration of Foxp3
þ Treg numbers in Il2
 / Bim
 / 
mice did not prevent the lymphoproliferative disease unless
exogenous IL-2 was added, suggesting that IL-2 is also
required for the function of Tregs in vivo.
28 It has been
reported that IL-2 and signaling through the IL-2R regulates
Bcl-2expression.
29 Ourdatasupportsthis observationasIL-2
deprivationresulted ina signiﬁcantdecrease inboth Bcl-2and
Bcl-xl expression in vitro. Taken together, this strongly
suggests an IL-2-dependent link between Bim and Bcl-2
levels,andsupportsourconclusionthatintheabsenceofBim,
there is increased survival of iTregs and consequently a
higher number of Tregs. How this relates to a decrease in IBD
incidence may be two-fold. First, in the absence of Bim, there
may be a reduction in apoptosis resulting in more iTregs.
Figure 5 Identiﬁcation of Foxp3
þBcl2
lo regulatory T-cell population in vivo.
(a and b) Cells isolated from the peripheral lymph nodes or spleens were stained
with Foxp3, Bcl-2 and surface markers indicated. (b) CD4
þFoxp3
þ cells were
stained for Bcl-2, CD44 and CD69. Data represent analysis of ﬁve independent
experiments
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Cell Death and DiseaseSecond, the increased number of Bim
 /  iTregs results in a
lower ratio of Tconv/iTregs in the tissues (spleen, WT –.86:1,
Bim
 /  – 22:1; MLN, WT – 31:1, Bim
 /  – 20:1; Gut, WT –
303:1, Bim
 /  – 120:1), which may increase the probability
that Bim-deﬁcient iTregs outcompete Tconv for the available
IL-2 that is required for optimal Treg suppression in vivo.
28
Although the notion that different T-cell subpopulations may
preferentially use different pro- and anti-apoptotic pathways to
regulate homeostasis has been previously proposed,
30 no
clear exampleshave beendocumented. Ourdata suggestthat
balanced expression within the Bim/Bcl-2 axis has a greater
impact on the survival of iTregs than activated Tconv in vitro
and in vivo. It is possible that lineage-speciﬁc transcription
factors may preferentially modulate the expression of speciﬁc
Bcl-2 family apoptotic modulator(s). A previous ChIP–ChIP
study revealed that Foxp3 is constitutively bound to the Bcl-2
locus, but not any other Bcl-2 family members.
31 It remains
unclear whether such binding promotes or represses Bcl-2
expression. Although depletion of the Foxp3-recruited tran-
scriptionalrepressorEosresultsinincreasedBcl-2expression,
iTregsthemselvesexpressmoreBcl-2than activatedTconv.
21
A moreintriguinghypothesis isthat Foxp3 may modulate Bcl-2
expression in a conditional manner. By recruiting different
nuclear factors, Foxp3 may promote Bcl-2 expression when
IL-2 is in excess, but repress Bcl-2 expression when IL-2 is
limited. This may be particularly relevant in speciﬁc diseases
such as autoimmune diabetes, in which defective IL-2
production has been documented.
32 If Foxp3 is directly
modulating Bcl-2 expression in Tregs, it is unclear whether
nTregs, like iTregs, are also hypersensitive to apoptosis.
A decreased Treg/Tconv cell ratio has been implicated in
the onset of autoimmune diabetes.
32 Indeed, consistent with
our ﬁnding that iTregs have a greater apoptotic tendency
in vitro and in vivo, profound Treg apoptosis has been shown
to occur during diabetes onset.
32 Interestingly, our study
suggests that there may be two subpopulations of Tregs
expressing different levels of Bcl-2, and it is the Bcl-2
hi
population that is preferentially lost during progression
towards diabetes. The majority of the detectable Tregs in
islets are phenotypically CD4
þFoxp3
þBcl-2
loKi67
þ, which
may represent newly differentiated iTregs at the site of
inﬂammation. In summary, the balance between Tregs and
Tconv has a central role in maintaining immune tolerance and
promoting immune response. Perturbation of the Bim/Bcl-2
balance may represent a new therapeutic approach to
modulate the immune environment under diverse disease
conditions. Modulation of Bcl-2 expression could be used as
an approach to promote survival of iTregs generated for
therapeutic application.
Materials and Methods
Mice, T-cell preparation and antibodies. C57BL/6 (WT) and Rag1
 / 
mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). The
Bim
 / micewereprovidedbyAndreasStrasser(TheWalterandElizaHallInstitute
of Medical Research, Parkville, Victoria, Australia).
12 The Bim
 /  mice were
crossed with Foxp3
GFP reporter mice
2 to generate Bim
 / Foxp3
GFP mice. All mice
were bred and maintained at St. Jude Children’s Research Hospital. All animal
experiments were performed in the American Association for the Accreditation of
Laboratory Animal Care-accredited, speciﬁc pathogen-, Helicobacter- and MNV-
free facilities, following national, state and institutional guidelines. Animal protocols
were approved by the St. Jude Animal Care and Use Committee.
For IEL/LPL puriﬁcation, intestines were removed, cut into 0.5cm pieces and
shakenat371Cfor20minin45mlHBSSwith1mMDTT.Suspensionwasdecanted
and ﬁltered through a 70mm cell strainer into a 50ml conical tube, and tissue was
pelleted by centrifugation for 5min at 1200r.p.m. Supernatant was discarded and
pellet was reserved on ice. This process was repeated two more times with the
strained tissue, pelleting the suspension in the same 50ml conical tube. The
remaining intestinal tissue was ﬁnely chopped and incubated in 25ml RPMI
supplemented with 10% FBS and 8000U of Collagenase Type IV (Worthington
Biochemical, Lakewood, NJ, USA), rotating at 371C. Cell suspension was strained
and pooled with the previous pelleted collection, centrifuged and supernatant
discarded. This was repeated with the strained intestinal tissue. The ﬁnal cell pellet
was washed in RPMI/10% FBS, centrifuged and supernatant discarded. The cell
pellet was resuspended in 4ml of 40  percoll (4.0ml of 100  percollþ6.0ml
RPMI/10% FBS; GE Healthcare, Piscataway, NJ, USA) and strained through a
70mm cell strainer. Cell suspension was gently layered over 5.0ml of 100  percoll
in a 15ml conical tube and centrifuged at 2500r.p.m. with no brake for 20min at
roomtemperature. Mediaoverlyingtheband of IEL/LPL at theinterfacebetween the
two percoll layers was carefully removed. The band of cells was transferred by
pipette to a new 15ml conical tube to which RPMI/10% FBS was added to a ﬁnal
volumeof10ml.Thetubewasshakenandcentrifuged10minat1500r.p.m.topellet
thecells.For Tconv andTreg preparation, spleens andlymph nodesfrom mice were
processed and stained with ﬂuorochrome-conjugated antibodies and puriﬁed by
single-cell sorting using anti-CD4 (clone GK 1.5), anti-CD25 (clone PC61) and anti-
CD45RB (clone C363-16A). Tconv used in this study were deﬁned as
CD4
þCD45RB
hiCD25
 , or if the Foxp3
GFP reporter mice were used, CD4
þGFP
 .
All antibodies used were from Biolegend (San Diego, CA, USA) or eBiosciences
(San Diego, CA, USA). Bcl-2 expression was determined using clone 10C4, and
staining performed with Foxp3 ﬁxation/permeablization reagents from eBioscience.
IBD model. Induction of IBD was performed as described previously.
33 Brieﬂy,
0.4 10
6 FACS-puriﬁed Tconv (CD4
þCD45RB
hiCD25
 ) were injected via the tail
vein into Rag1
 /  mice. The Tconv recipients were monitored and the clinical sign
of disease was deﬁned as 5–10% body-weight loss. Spleen, lymph node and IEL/
LPLcellularitywasanalyzedapproximately4weekspost-Tconvtransfer.Forexvivo
analysis of gene expression pattern, iTregs and Tconv were sorted 4 weeks post-
transfer.
AnalysisofIL-2byELISAandintracellularstaining. WTandBim
 / 
Tconvwere sortedand platedin 96-wellround-bottomplates(1 10
5 per well)with
anti-CD3/CD28-coated M-450 tosylactivated dynabeads (Invitrogen, Grand Island,
NY, USA) at a ratio of 2.5 cells per bead. After 72h stimulation, supernatants were
collected and analyzed by ELISA. Supernatants were incubated on plates pre-
coated with 1mg/ml puriﬁed anti-IL2 (clone JES6-1A12, Biolegend) for 2h at room
temperature. Then, IL-2 was detected with 1mg/ml biotinylated anti-IL-2 (clone
JES6-5H4 biotin, Biolegend), followed by streptavidin-HRP (Jackson
Immunoresearch Laboratories Inc., West Grove, PA, USA) and developed with
TMB substrate (Thermo Fisher Scientiﬁc, Pittsburgh, PA, USA).
For intracellular staining, spleen and MLN of Rag1
 /  that had received WT or
Bim
 /  Tconv 4 weeks prior were processed, and the cells were stimulated for 12h
with PMA/ionomycin (100ng/ml and 500ng/ml, respectively) in the presence of
Brefeldin A (1:1000, Biolegend). Following stimulation, cells were stained for
surface CD4 and CD25, ﬁxed and stained with antibodies to IL-2 (clone JES5-5H4)
or an IgG isotype control, using Cytoﬁx/Cytoperm kit following the manufacturer’s
instruction(BDBiosciences,SanDiego,CA,USA),andanalyzedbyﬂowcytometry.
Intracellular staining for Bcl-2 and Foxp3. Puriﬁed Tconv (CD4
þ
CD45RB
hiCD25
 ) were injected i.v. via the tail vein into Rag1
 /  mice. After 4
weeks, spleen and MLN were processed and cells were stained for surface CD4,
andthenﬁxed,permeabilizedandstainedwithantibodiestoBcl2(cloneBCL/10C4),
Foxp3 (clone 150D) and an IgG1 isotype control, using the Foxp3 Fixation/
Permeabilization buffer set from EBiosciences according to manufacturer’s
instructions, and analyzed by ﬂow cytometry.
BrdUanalysis. PuriﬁedTconvwereinjectedviathetailveinintoRag1
 / mice.
At 4 weeks post-transfer, mice were injected i.p. with 200ml of BrdU (10mg/ml) in
PBS.After16h,cellsfromspleenandMLNwereharvested,stainedforCD4,Foxp3
and BrdU, using the BrdU-APC ﬂow kit (BD Biosciences) following manufacturer’s
instructions, and analyzed by ﬂow cytometry.
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analysis. Tconv were isolated from WT or Bim
 /  Foxp3
GFP reporter mice
and activated with either plate-bound anti-CD3 (clone 2C11) and soluble anti-CD28
(clone 37.51) or pre-coated CD3/CD28 beads in the presence of 5ng/ml TGF-b and
100U/ml IL-2 for 3 days. GFP
þ iTreg and activated GFP
  Tconv were sorted by
FACS.Either cell typewas thencultured withor withoutexogenous IL-2at acell density
of5 10
4perwellin96-wellround-bottomplatesforthetimesindicated.Sampleswere
collected and stained with eFluor-670 (eBiosciences), AnnexinV (BD Biosciences) and
PI (Sigma-Aldrich, St. Louis, MO, USA). Live cells were deﬁned as AnnexinV
 PI
 .
Quantitative real-time PCR. RNA was puriﬁed using Qiagen (Valencia, CA,
USA) RNeasy Plus Mini or RNeasy Micro kit following the manufacturer’s
instructions. The expression level of Bim, Bcl-2, Bcl-xl, Bax, Bid, Mcl1 and Noxa
were quantiﬁed by real-time PCR on a 7900HT Fast Real-Time PCR System
(Applied Biosystems, Foster City, CA, USA) using SYBR green. Taqman probe-
basedquantitativePCRwas usedto recordactinexpressionlevelfor normalization.
Primer sets were as follows: bcl2-F: 50-ACTTCGCAGAGATGTCCAGTCA-30,
bcl2-R: 50-TGGCAAAGCGTCCCCTC-30; bcl-xl-F: 50-GAATGGAGCCACTGGCC
A-30, bcl-xl-R: 50-GCTGCCATGGGAATCACCT-30; bax-F: 50-GCCTCCTCTCCTA
CTTCGGG-30, bax-R: 50-TGAGGACTCCAGCCACAAAGA-30; Bim-F: 50-TGCGC
CCGGAGATACG-30, Bim-R: 50-TTCGTTGAACTCGTCTCCGA-30; Bid-F: 50-GCT
GTCTCCCTATTTCCAGGTG-30, Bid-R: 50-AGCTGAACGCAGAGATGTCCA-30;
Noxa-F: 50- GTCGCAAAAGAGCAGGATGAG-30, Noxa-R: 50-TTGAGCACACTC
GTCCTTCAA-30; Mcl-1F: 50-AACGGGACTGGCTTGTCAAA-30, Mcl-1R: 50-CTA
GGTCCTGTACGTGGAAGAACTC-30.
Statistics. Data were analyzed using paired, unpaired t-test or Mann–Whitney
test, depending upon the data set, and is described in the ﬁgure legends. For
analysis of disease incidence in Figure 1f, a 2 2 w
2-analysis was used. P-values
were categorized into three levels: *Po0.05, **Po0.01 and ***Po0.005, unless
stated otherwise.
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